Concepedia

Bingbing Yang

BY

Statistics

Publications

39

Citations

2K

H-Index

21

Active since

1996

Affiliations

Amgen (United States)(Current)

Tianjin Medical University General Hospital

Chinese Academy of Sciences

Warde Medical Laboratory

Chinese Academy of Forestry

Bingbing Yang is an author at Amgen (United States) specializing in pharmacology, pharmacokinetics, and medicine.

ORCID

Publications per year

1996–2025

39

Publications

39

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer

Frankie A. Holmes, Stephen E. Jones, Joyce O’Shaughnessy et al. · Annals of Oncology · 2002 · 292 citations · Full text

, , +11

Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy

Eileen Johnston, Jeffrey Crawford, Susan Blackwell et al. · Journal of Clinical Oncology · 2000 · 268 citations

, , +17

Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages

Yong Li, Fengjun Cao, Mingxing Li et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 141 citations · Full text

, , +17

Pharmacokinetics of anakinra in subjects with different levels of renal function

Bingbing Yang · Clinical Pharmacology & Therapeutics · 2003 · 132 citations

, , +17

Pharmacokinetic/Pharmacodynamic Modeling of Pegfilgrastim in Healthy Subjects

Lorin Roskos, Peggy Lum, Pamela Lockbaum et al. · The Journal of Clinical Pharmacology · 2006 · 128 citations

, , +14

1–5 of 39